Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases

Cancer Genetics and Cytogenetics

Volumn 200, Issue 2, 2010, Pages 154-160

  Kulda, Vlastimil ^a   Pesta, Martin ^a   Topolcan, Ondrej ^a   Liska, Vaclav ^a   Treska, Vladislav ^a   Sutnar, Alan ^a   Rupert, Karel ^a   Ludvikova, Marie ^a   Babuska, Vaclav ^a   Holubec, Lubos ^a   Cerny, Radim ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MICRORNA; MICRORNA 143; MICRORNA 21; OXALIPLATIN; RALTITREXED; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLORECTAL CARCINOMA; DISEASE FREE INTERVAL; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER SURGERY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED;

EID: 77953767473     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.04.015     Document Type: Article

References (31)

1. Czech Health Statistics Yearbook 2008. UZIS CR, Prague, Czech Republic, 2009. Available at: Last accessed March 1, 2010. http://www.uzis.cz/download_file.php?file=3626.
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
3. Tops C.M., Wijnen J.T., Hes F.J. Introduction to molecular and clinical genetics of colorectal cancer syndromes. Best Pract Res Clin Gastroenterol 2009, 23:127-146.
4. Bertholon J., Wang Q., Galmarini C.M., Puisieux A. Mutational targets in colorectal cancer cells with microsatellite instability. Fam Cancer 2006, 5:29-34.
5. Abdel-Rahman W.M., Peltomäki P. Molecular basis and diagnostics of hereditary colorectal cancers. Ann Med 2004, 36:379-388.
6. Chen X., Guo X., Zhang H., Xiang Y., Chen J., Yin Y., et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009, 28:1385-1392.
7. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008, 18:350-359.
8. Croce C.M. Oncogenes and cancer. N Engl J Med 2008, 358:502-511.
9. Ludvikova M., Pesta M., Holubec L., Kalfert D. [New aspects of tumor pathobiology]. Cesk Patol 2009, 45:94-99. (in Czech).
10. Si M.L., Zhu S., Wu H., Lu Z., Wu F., Mo Y.Y. miR-21-mediated tumor growth. Oncogene 2007, 26:2799-2803.
11. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435:839-843.
12. Zhu S., Si M.L., Wu H., Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007, 282:14328-14336.
13. Zhang Z., Li Z., Gao C., Chen P., Chen J., Liu W., et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008, 88:1358-1366.
14. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
15. Fabbri M., Ivan M., Cimmino A., Negrini M., Calin G.A. Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin Biol Ther 2007, 7:1009-1019.
16. Choong M.L., Yang H.H., McNiece I. MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp Hematol 2007, 35:551-564.
17. Corney D.C., Flesken-Nikitin A., Godwin A.K., Wang W., Nikitin A.Y. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007, 67:8433-8438.
18. Ng E.K., Chong W.W., Jin H., Lam E.K., Shin V.Y., Yu J., et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
19. Peters I.R., Helps C.R., Calvert E.L., Hall E.J., Day M.J. Cytokine mRNA quantification in duodenal mucosa from dogs with chronic enteropathies by real-time reverse transcriptase polymerase chain reaction. J Vet Intern Med 2005, 19:644-653.
20. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004, 4:769-780.
21. Bellizzi A.M., Frankel W.L. Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol 2009, 16:405-417.
22. Bougatef K., Ouerhani S., Moussa A., Kourda N., Coulet F., Colas C., et al. Prevalence of mutations in APC, CTNNB1, and BRAF in Tunisian patients with sporadic colorectal cancer. Cancer Genet Cytogenet 2008, 187:12-18.
23. Schetter A.J., Leung S.Y., Sohn J.J., Zanetti K.A., Bowman E.D., Yanaihara N., et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299:425-436.
24. Markou A., Tsaroucha E.G., Kaklamanis L., Fotinou M., Georgoulias V., Lianidou E.S. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 2008, 54:1696-1704.
25. microCosm, TargetScan, Pictar. Available at: Accessed March 1, 2010. http://www.mirbase.org/.
26. Bandres E., Cubedo E., Agirre X., Malumbres R., Zarate R., Ramirez N., et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006, 5:29.
27. Slaby O., Svoboda M., Fabian P., Smerdova T., Knoflickova D., Bednarikova M., et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007, 72:397-402.
28. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64:3753-3756.
29. Spizzo R., Nicoloso M.S., Croce C.M., Calin G.A. SnapShot: microRNAs in cancer. Cell 2009, 137:586.
30. Nakajima G., Hayashi K., Xi Y., Kudo K., Uchida K., Takasaki K., et al. Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 2006, 3:317-324.
31. Peltier H.J., Latham G.J. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 2008, 14:844-852.